Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 17, 2016 - Issue 13
Submit an article Journal homepage
480
Views
13
CrossRef citations to date
0
Altmetric
Treatment Evaluation

Buprenorphine dosing choices in specific populations: review of expert opinion

Icro MaremmaniDepartment of Neurosciences, Santa Chiara University Hospital, University of Pisa, Pisa, ItalyView further author information
,
Benjamin RollandDepartments of Addiction Medicine and Pharmacology, INSERM, University Hospital of Lille, Lille, FranceView further author information
,
Lorenzo SomainiAddiction Treatment Centre, Biella, ItalyView further author information
,
Carlos RonceroAddiction and Dual Diagnosis Unit, Department of Psychiatry, Vall d’Hebron Hospital, Barcelona, SpainView further author information
,
Jens ReimerDirector at Centre for Interdisciplinary Addiction Research, University Medical Centre Hamburg-Eppendorf, Martini Strasse, GermanyView further author information
,
Nat WrightSpectrum Community Health CIC, Wakefield, UKView further author information
,
Richard LittlewoodApplied Strategic, London, UKView further author information
,
Peter KrajciDivision of Mental Health and Addiction, Department of Substance Use Disorder Treatment, Oslo University Hospital, Oslo, NorwayView further author information
,
Hannu AlhoHA, Clinicum, University of Helsinki and University Hospital, Helsinki, FinlandCorrespondence[email protected]
View further author information
,
Oscar D’AgnoneFaculty of Medical and Human Sciences, Institute of Brain Behaviour and Mental Health, University of Manchester, Manchester, UKView further author information
&
Nicolas SimonService de Pharmacologie Clinique, Sainte Marguerite Hospital, Marseille, France;Department of Clinical Pharmacology, Medical School of Marseilles, Marseille, France;Aix Marseille University, INSERM, UMR 912 IRD, SESSTIM, Marseille, FranceView further author information
 show all
Pages 1727-1731 | Received 24 May 2016, Accepted 01 Jul 2016, Published online: 02 Aug 2016

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Sheryl Ker, Jennifer Hsu, Anisha Balani, Sankha Subhra Mukherjee, A John Rush, Mehreen Khan, Sara Elchehabi, Seth Huffhines, Dustin DeMoss, Miguel E Rentería & Joydeep Sarkar. (2021) Factors That Affect Patient Attrition in Buprenorphine Treatment for Opioid Use Disorder: A Retrospective Real-World Study Using Electronic Health Records. Neuropsychiatric Disease and Treatment 17, pages 3229-3244.
Read now
Maurice Dematteis, Marc Auriacombe, Oscar D’Agnone, Lorenzo Somaini, Néstor Szerman, Richard Littlewood, Farrukh Alam, Hannu Alho, Amine Benyamina, Julio Bobes, Jean Pierre Daulouede, Claudio Leonardi, Icro Maremmani, Marta Torrens, Stephan Walcher & Michael Soyka. (2017) Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus. Expert Opinion on Pharmacotherapy 18:18, pages 1987-1999.
Read now

Articles from other publishers (11)

Heather Burrell Ward, Charles B. Nemeroff, Linda Carpenter, Adrienne Grzenda, William M. McDonald, Carolyn I. Rodriguez & Nina Vanessa Kraguljac. (2023) Substance use disorders in schizophrenia: Prevalence, etiology, biomarkers, and treatment. Personalized Medicine in Psychiatry 39-40, pages 100106.
Crossref
Fatima Maqoud, Giada Fabio, Nunzio Ciliero, Marina Antonacci, Francesca Mastrangelo, Giorgio Sammarruco, Roberto Cataldini, Gabriella Schirosi, Salvatore De Fazio & Domenico Tricarico. (2022) Multicenter Observational/Exploratory Study Addressed to the Evaluation of the Effectiveness and Safety of Pharmacological Therapy in Opioid-Dependent Patients in Maintenance Therapy in Southern Italy. Pharmaceutics 14:2, pages 461.
Crossref
Mathieu Chappuy, Benoit Trojak, Philippe Nubukpo, Jérôme Bachellier, Patrick Bendimerad, Georges Brousse & Benjamin Rolland. (2020) Prolonged-release buprenorphine formulations: Perspectives for clinical practice. Therapies 75:5, pages 397-406.
Crossref
Matteo Pacini, Angelo G. I. Maremmani & Icro Maremmani. (2020) The Conceptual Framework of Dual Disorders and Its Flaws. Journal of Clinical Medicine 9:7, pages 2098.
Crossref
Mathieu Chappuy, Benoit Trojak, Philippe Nubukpo, Jérôme Bachellier, Patrick Bendimerad, Georges Brousse & Benjamin Rolland. (2020) Buprénorphine d’action prolongée : quelles perspectives pour la pratique clinique ?. Therapies.
Crossref
Shaoling Zhong, Rongqin Yu & Seena Fazel. (2020) Drug Use Disorders and Violence: Associations With Individual Drug Categories. Epidemiologic Reviews 42:1, pages 103-116.
Crossref
Wenwen Shen, Qing Wang, Jianbin Zhang, Wenkai Ping, Jiawen Zhang, Weiting Ye, Qianyu Hu, Deniz Cerci & Wenhua Zhou. (2019) A Retrospective Survey of Buprenorphine Substitute Treatment With Minimal Dosage in Heroin Use Disorder. Frontiers in Psychiatry 10.
Crossref
Kristiina Kivimies, Eila Repo-Tiihonen, Hannu Kautiainen & Jari Tiihonen. (2018) Comorbid opioid use is undertreated among forensic patients with schizophrenia. Substance Abuse Treatment, Prevention, and Policy 13:1.
Crossref
Saul Alcaraz, Francisco González-Saiz, Joan Trujols, Esperanza Vergara-Moragues, Núria Siñol & José Pérez de los Cobos. (2018) A cluster-analytic profiling of heroin-dependent patients based on level, clinical adequacy, and patient-desired adjustment of buprenorphine dosage during buprenorphine-naloxone maintenance treatment in sixteen Spanish centers. Drug and Alcohol Dependence 187, pages 278-284.
Crossref
Jason Baker Fields, William F. Haning & Yngvild Olsen. 2018. The American Society of Addiction Medicine Handbook on Pain and Addiction. The American Society of Addiction Medicine Handbook on Pain and Addiction 221 242 .
Katherine A. Lyseng-Williamson. (2017) Buprenorphine oral lyophilisate (Espranor®) in the substitution treatment of opioid dependence: a profile of its use. Drugs & Therapy Perspectives 33:6, pages 241-248.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.